Tag: JAK Inhibitor

FDA Approves Olumiant for Adolescents with Severe Alopecia Areata

FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…

ME Desk

FDA Approves Merckโ€™s NUMELVI for Allergic Dermatitis in Dogs

Merck Animal Health has received FDA approval for NUMELVIโ„ข (atinvicitinib), a next-generation…

ME Desk

European Commission Approves NUMELVI Tablets for Dogs

Merck Animal Health, known as MSD Animal Health outside of the United…

ME Desk